Anlotinib combined with chemotherapy and immunotherapy for advanced pulmonary sarcomatoid cancer: A case report and literature review
Pulmonary sarcomatoid carcinoma (PSC) is a rare disease which is highly malignant with a poor prognosis. PSC is highly resistant to chemotherapy and radiotherapy and is prone to recurrence even after surgery. Most of what is known about PSC comes from limited single-center, retrospective studies. Th...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Published: |
Ame Publishing Company
2022
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/40888/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|